MeVis Medical Solutions AGXTER:M3V 66 PB Ratio is 2.47 as of Jul. 09, 2026, which is 12% below its 10-year median of 2.82. GuruFocus rates XTER:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.91 (Fairly Valued). The stock has 5 warning signs investors should review. Among 609 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks worse than 58.78% on this metric.
MeVis Medical Solutions AG stock PB Ratio (=2.47) is close to 5-year low of 2.27.
The historical rank and industry rank for MeVis Medical Solutions AG's PB Ratio or its related term are showing as below:
XTER:M3V'
s PB Ratio Range Over the Past 10 Years
Min: 1.48 Med: 2.82 Max: 3.78
Current: 2.47
During the past 13 years, MeVis Medical Solutions AG's highest PB Ratio was 3.78. The lowest was 1.48. And the median was 2.82.
XTER:M3V's PB Ratio is ranked worse than 58.78% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 2
vs XTER:M3V: 2.47
During the past 12 months, MeVis Medical Solutions AG's average Book Value Per Share Growth Rate was -1.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -6.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of MeVis Medical Solutions AG was 134.60% per year. The lowest was -19.10% per year. And the median was 0.00% per year.
Back to Basics: PB Ratio
MeVis Medical Solutions AG (XTER:M3V) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MeVis Medical Solutions AG PB Ratio Related Terms
MeVis Medical Solutions AG PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, MeVis Medical Solutions AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MeVis Medical Solutions AG (XTER:M3V) has a PB Ratio of 2.47 as of Jul. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MeVis Medical Solutions AG and its competitors. This is 12% below median its historical median of 2.82. Over the past decade, MeVis Medical Solutions AG's PB Ratio has ranged from 1.48 to 3.78. According to the industry distribution chart, MeVis Medical Solutions AG ranks #358 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 58.8%.
Is MeVis Medical Solutions AG's PB Ratio too high?
MeVis Medical Solutions AG's current PB Ratio of 2.47 is 12% below median its 10-year median of 2.82. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 3.78. The Healthcare Providers & Services industry median PB Ratio is 2.00. MeVis Medical Solutions AG's value of 2.47 is 23.5% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #358 out of 609 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #358 out of 609 companies for PB Ratio. This places MeVis Medical Solutions AG in the lower half of its industry. The industry median PB Ratio is 2.00. MeVis Medical Solutions AG's value of 2.47 is 23.5% above this benchmark. Historically, MeVis Medical Solutions AG's own PB Ratio has ranged from 1.48 to 3.78 over the past decade. While the company's 10-year median is 2.82 vs. the industry median of 2.00, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.00, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current PB Ratio of 2.47 is 23.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current PB Ratio is 2.47, which is 12% below median its own 10-year median of 2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
Based on GuruFocus' analysis, MeVis Medical Solutions AG (XTER:M3V) is currently considered Fairly Valued. The stock's GF Value™ is €22.91, compared to a current price of €24.20 — trading 5.6% above its estimated fair value. The current PB Ratio is 2.47, which is 12% below median its 10-year median of 2.82 and 23.5% above the Healthcare Providers & Services industry median of 2.00. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MeVis Medical Solutions AG (XTER:M3V), the current PB Ratio is 2.47 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (XTER:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.20 is trading 5.6% above its estimated GF Value™ of €22.91.
GuruFocus considers MeVis Medical Solutions AG to be Fairly Valued.
Key valuation signals for XTER:M3V:
PB Ratio: 2.47 (12% below median its 10-year median of 2.82)
GF Value™: €22.91 vs. price of €24.20 (5.6% above fair value)
Industry Position: 23.5% above the Healthcare Providers & Services median (#358 of 609)
No single metric tells the full story. See the XTER:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for XTER:M3V
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:M3V has been successfully added to your 
